Post-cardiotomy venovenous extracorporeal membrane oxygenation without heparinization. 2019

Masami Takagaki, and Hiroki Yamaguchi, and Naoko Ikeda, and Kaori Takeda, and Fumihito Kasai, and Kiyotaka Yahagi, and Shunji Kanzaki, and Shinichi Mitsuyama, and Tasuku Kadowaki, and Toru Kotani
Department of Cardiovascular Surgery, Showa University Koto Toyosu Hospital, 5-1-38 Toyosu, Koto-ku, Tokyo, 135-8577, Japan.

We present the cases of eight patients (mean age 75 years; EuroSCORE II 17.0 ± 22.0) who underwent post-cardiotomy venovenous extracorporeal membrane oxygenation (ECMO) without heparinization due to serious bleeding. Three liver cirrhosis, two chronic hemodialysis, three redo sternotomy, and two urgent surgery cases were included. Respiratory ECMO Survival Prediction score was - 5.1 ± 4.2 (estimated survival rate: approximately 30%). Mean ECMO duration was 14 days with 9 circuit exchanges. Five patients were weaned from ECMO and three were discharged alive at 90 days (survival 37.5%). There was a case of pump-head thrombosis requiring urgent circuit exchange. All experienced bleeding complications without clinically apparent pulmonary thromboembolism. Disseminated Intravascular Coagulation scores (Pre 1.3 ± 0.8 vs. Post 3.8 ± 1.7; p < 0.05) significantly increased (N = 6). Post-cardiotomy ECMO without heparinization facilitated patient rescue at a reasonable survival rate. However, bleeding complications were still observed. More sophisticated management protocols are warranted.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006348 Cardiac Surgical Procedures Surgery performed on the heart. Cardiac Surgical Procedure,Heart Surgical Procedure,Heart Surgical Procedures,Procedure, Cardiac Surgical,Procedure, Heart Surgical,Procedures, Cardiac Surgical,Procedures, Heart Surgical,Surgical Procedure, Cardiac,Surgical Procedure, Heart,Surgical Procedures, Cardiac,Surgical Procedures, Heart
D006470 Hemorrhage Bleeding or escape of blood from a vessel. Bleeding,Hemorrhages
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075203 Contraindications, Drug A condition or factor associated with a recipient that makes the use of a specific drug improper or inadvisable. Drug Contraindications,Contraindication, Drug,Drug Contraindication
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect

Related Publications

Masami Takagaki, and Hiroki Yamaguchi, and Naoko Ikeda, and Kaori Takeda, and Fumihito Kasai, and Kiyotaka Yahagi, and Shunji Kanzaki, and Shinichi Mitsuyama, and Tasuku Kadowaki, and Toru Kotani
October 2018, Journal of cardiothoracic and vascular anesthesia,
Masami Takagaki, and Hiroki Yamaguchi, and Naoko Ikeda, and Kaori Takeda, and Fumihito Kasai, and Kiyotaka Yahagi, and Shunji Kanzaki, and Shinichi Mitsuyama, and Tasuku Kadowaki, and Toru Kotani
July 2013, General thoracic and cardiovascular surgery,
Masami Takagaki, and Hiroki Yamaguchi, and Naoko Ikeda, and Kaori Takeda, and Fumihito Kasai, and Kiyotaka Yahagi, and Shunji Kanzaki, and Shinichi Mitsuyama, and Tasuku Kadowaki, and Toru Kotani
December 2012, Cardiology in the young,
Masami Takagaki, and Hiroki Yamaguchi, and Naoko Ikeda, and Kaori Takeda, and Fumihito Kasai, and Kiyotaka Yahagi, and Shunji Kanzaki, and Shinichi Mitsuyama, and Tasuku Kadowaki, and Toru Kotani
October 2020, Perfusion,
Masami Takagaki, and Hiroki Yamaguchi, and Naoko Ikeda, and Kaori Takeda, and Fumihito Kasai, and Kiyotaka Yahagi, and Shunji Kanzaki, and Shinichi Mitsuyama, and Tasuku Kadowaki, and Toru Kotani
October 2020, The Annals of thoracic surgery,
Masami Takagaki, and Hiroki Yamaguchi, and Naoko Ikeda, and Kaori Takeda, and Fumihito Kasai, and Kiyotaka Yahagi, and Shunji Kanzaki, and Shinichi Mitsuyama, and Tasuku Kadowaki, and Toru Kotani
September 2022, Translational pediatrics,
Masami Takagaki, and Hiroki Yamaguchi, and Naoko Ikeda, and Kaori Takeda, and Fumihito Kasai, and Kiyotaka Yahagi, and Shunji Kanzaki, and Shinichi Mitsuyama, and Tasuku Kadowaki, and Toru Kotani
March 2021, Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs,
Masami Takagaki, and Hiroki Yamaguchi, and Naoko Ikeda, and Kaori Takeda, and Fumihito Kasai, and Kiyotaka Yahagi, and Shunji Kanzaki, and Shinichi Mitsuyama, and Tasuku Kadowaki, and Toru Kotani
August 2021, European heart journal. Acute cardiovascular care,
Masami Takagaki, and Hiroki Yamaguchi, and Naoko Ikeda, and Kaori Takeda, and Fumihito Kasai, and Kiyotaka Yahagi, and Shunji Kanzaki, and Shinichi Mitsuyama, and Tasuku Kadowaki, and Toru Kotani
March 2017, The Journal of thoracic and cardiovascular surgery,
Masami Takagaki, and Hiroki Yamaguchi, and Naoko Ikeda, and Kaori Takeda, and Fumihito Kasai, and Kiyotaka Yahagi, and Shunji Kanzaki, and Shinichi Mitsuyama, and Tasuku Kadowaki, and Toru Kotani
March 2014, The journal of extra-corporeal technology,
Copied contents to your clipboard!